Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Alexion Pharmaceuticals Company Profile (NASDAQ:ALXN)

Consensus Ratings for Alexion Pharmaceuticals (NASDAQ:ALXN) (?)
Ratings Breakdown: 5 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.62)
Consensus Price Target: $181.44 (8.02% upside)

Current Analysts' Coverage Summary for Alexion Pharmaceuticals (NASDAQ:ALXN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/10/2014ZacksDowngradeOutperform -> Neutral$173.00ViewTweet This Rating  Share This Rating on StockTwits
5/9/2014JPMorgan Chase & Co.Reiterated RatingOverweight$200.00 -> $210.00ViewTweet This Rating  Share This Rating on StockTwits
4/25/2014Stifel NicolausReiterated RatingBuy$219.00 -> $220.00ViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
3/27/2014Credit SuisseBoost Price TargetNeutral$171.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2014Robert W. BairdBoost Price Target$175.00 -> $199.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2014Brean CapitalBoost Price Target$200.00 -> $215.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2014NomuraBoost Price Target$214.00 -> $222.00ViewTweet This Rating  Share This Rating on StockTwits
3/6/2014BarclaysBoost Price TargetOutperform$181.00 -> $193.00ViewTweet This Rating  Share This Rating on StockTwits
2/10/2014Deutsche BankBoost Price TargetBuy$125.00 -> $205.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014Jefferies GroupBoost Price TargetHold$106.00 -> $145.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014Leerink SwannBoost Price Target$125.00 -> $200.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014Canaccord GenuityBoost Price TargetBuy$161.00 -> $200.00ViewTweet This Rating  Share This Rating on StockTwits
1/6/2014Goldman SachsDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
11/26/2013Piper JaffrayInitiated CoverageOverweight$172.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013OppenheimerBoost Price Target$115.00 -> $125.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013GuggenheimBoost Price TargetBuy$127.00 -> $130.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013Cowen and CompanyBoost Price TargetOutperform$115.00 -> $123.00ViewTweet This Rating  Share This Rating on StockTwits
4/25/2013Wells Fargo & Co.Reiterated RatingMarket PerformViewTweet This Rating  Share This Rating on StockTwits
4/19/2013TheStreetReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
2/20/2013Lazard LtdUpgradeNeutral -> Buy$102.00ViewTweet This Rating  Share This Rating on StockTwits
2/15/2013Bank of AmericaReiterated RatingBuy$120.00 -> $124.00ViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Janney Montgomery ScottInitiated CoverageNeutral$107.00ViewTweet This Rating  Share This Rating on StockTwits
12/24/2012Citigroup Inc.Initiated CoverageNeutral$104.00ViewTweet This Rating  Share This Rating on StockTwits
8/24/2012ThinkEquityInitiated CoverageHold$105.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2012 forward)